Imkeldi 81927-0201-01
Generic: Imatinib Oral
- Manufacturer
- Shorla Oncology Inc.,
- Dosage Form
- Solution
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- December 19, 2024
- Listing Expires
- December 31, 2026
- Application
- NDA219097
Need to source Imkeldi? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Imatinib Mesylate | 80 mg/mL |
Drug Class
Bcr-Abl Tyrosine Kinase Inhibitors [MoA]Cytochrome P450 2D6 Inhibitors [MoA]Cytochrome P450 3A4 Inhibitors [MoA]
Selected Package
81927-0201-01Selected140 mL in 1 BOTTLE (81927-201-01)